OakChart

Nutex Health Inc

NUTXHealthcare·Medical Care Facilities·USA·Small·NASD·Nov 11 • 9:43 AM ET

189.87+3.62 (1.94%)
2026-11-11 15:44 CET
Market cap
1,277.82 USD m
Revenue, TTM
796.53 USD m
Net income, TTM
164.71 USD m
Free cash flow, TTM
248.10 USD m
EPS diluted, TTM
23.23
P/E
8.17
Compare

Price

NUTX against its 20, 50 and 200-day averages
2050200beat
100.00150.00200.00190K380KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NUTXclose 189.8720-day 197.2750-day 203.20200-day 151.78189.87

16.0% under 226.16 on 6 Oct 2026. Last 15 sessions, 32.4% high to low

Profile

NUTX
52-week range, 74% of the way up
83.99226.16

Nutex Health, Inc. engages in the management and operation of healthcare facilities. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Division establishes and operates provider networks such as independent physician associations (IPAs). The Real State Division owns land and hospital buildings which are leased to hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.

IndexRUT
Employees944
IPOApr 24, 2014
Beta0.68
ATR, 14d13.22
Rel volume0.21
Short float25.26%
Insider own32.87%
Inst own45.31%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.30B
Enterprise Value1.52B
Income164.71M
Sales796.53M
Book/sh63.52
Cash/sh36.96
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees944
IPOApr 24, 2014

Ratios

P/E8.17
Forward P/E6.87
PEG0.18
P/S1.64
P/B2.99
P/C5.14
P/FCF5.25
EV/EBITDA4.57
EV/Sales1.91
Quick Ratio4.72
Current Ratio4.76
Debt/Eq0.84
LT Debt/Eq0.80
Option/ShortNo / Yes

Earnings

EPS (ttm)23.23
EPS next Y27.63
EPS next Q5.98
EPS this Y165.45%
EPS next Y-0.67%
EPS next 5Y38.13%
EPS past 3/5Y- -
Sales past 3/5Y58.62% 253.48%
EPS Y/Y TTM17.73%
Sales Y/Y TTM-18.82%
EPS Q/Q-26.39%
Sales Q/Q-18.74%
EarningsNov 05 AMC
EPS/Sales Surpr.3.04% 1.30%

Ownership

Insider Own32.87%
Insider Trans-0.01%
Inst Own45.31%
Inst Trans2.13%
ROA16.50%
ROE43.76%
ROIC21.03%
Gross Margin47.79%
Oper. Margin39.04%
Profit Margin20.68%
SMA20-3.75%
SMA50-6.56%
SMA20025.09%
Trades-

Technical

Shs Outstand6.86M
Shs Float4.61M
Short Float25.26%
Short Ratio7.67
Short Interest1.16M
52W High226.16 -16.05%
52W Low83.99 126.06%
Volatility9.72% 7.16%
ATR (14)13.22
RSI (14)46.17
Beta0.68
Rel Volume0.21
Avg Volume151.93K
Volume2,587

Performance

Perf Week-7.48%
Perf Month-7.09%
Perf Quarter1.64%
Perf Half Y43.95%
Perf YTD15.34%
Perf Year69.57%
Perf 3Y427.42%
Perf 5Y-70.56%
Perf 10Y-96.38%
Recom1.00
Target Price309.83
Prev Close186.25
Price189.87
Change %1.94%

Analyst ratings

latest 7 of 7
DateActionAnalystRating changeTargetImplied
Oct 26, 2026InitiatedLLadenburg ThalmannBuy$336+77.0%
Sep 04, 2026ResumedRB. Riley SecuritiesBuy$325+71.2%
Jun 26, 2026InitiatedRB. Riley SecuritiesBuy$290+52.7%
Jun 02, 2026InitiatedLLake StreetBuy$235+23.8%
Nov 12, 2024ReiteratedMMaxim GroupBuy$45 → $50-73.7%
Sep 18, 2024InitiatedMMaxim GroupBuy$45-76.3%
Feb 22, 2023InitiatedNNorthland CapitalOutperform$3-98.4%

Peers

Mkt cap
TickerCompanyMkt cap
ARDTArdent Health Inc2.54B
CYHCommunity Health Systems Inc306.74M
SGRYSurgery Partners Inc3.48B
UHSUniversal Health Services Inc11.19B
ASTHAstrana Health Inc1.62B
CONConcentra Group Holdings Parent Inc5.40B
HCAHCA Healthcare Inc104.71B
MDPediatrix Medical Group Inc2.44B
THCTenet Healthcare Corp22.91B
PIIIP3 Health Partners Inc24.69M

Insider trading

latest 14 of 17
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Saunders Scott JDirectorSep 18 '26Sale214.2520343,493400Sep 18 02:51 PM
Jaumot Frank EDirectorJul 31 '26Option Exercise0.006030753Aug 03 10:10 AM
Grenas Cheryl YvonneDirectorJul 31 '26Option Exercise0.006030670Aug 03 10:07 AM
Saunders Scott JDirectorJul 31 '26Option Exercise0.006030603Aug 03 10:04 AM
Reed Michael LeeDirectorJul 31 '26Option Exercise0.006030670Aug 03 09:59 AM
Hosseinion WarrenPresidentMar 19 '26Buy94.0725223,7067,765Mar 23 01:21 PM
Jaumot Frank EDirectorMar 20 '26Buy93.5615014,033150Mar 23 01:11 PM
Spears KelvinDirectorMar 17 '26Buy94.461094532,137Mar 18 10:40 AM
Montgomery Pamela W.Chief Legal Officer-HealthcareMar 13 '26Buy88.87797,0212,758Mar 16 03:02 PM
Luqman Elisa VChief Legal Officer - SECMar 10 '26Option Exercise0.002,08403,154Mar 11 06:27 PM
Montgomery Pamela W.Chief Legal Officer-HealthcareMar 10 '26Option Exercise0.002,08403,455Mar 11 06:08 PM
Spears KelvinDirectorMar 10 '26Option Exercise0.00183032,209Mar 11 05:52 PM
Chang Michael L.Chief Medical OfficerMar 10 '26Option Exercise0.002,084083,125Mar 11 05:36 PM
Hosseinion WarrenPresidentMar 10 '26Option Exercise0.006,293010,787Mar 11 05:20 PM

Held by

AUM
TickerCompanyAUM
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
CALFPacer US Small Cap Cash Cows ETFAUM: 3.86B
FYCFirst Trust Small Cap Growth AlphaDEX FundAUM: 1.35B
SFLOVictoryShares Small Cap Free Cash Flow ETFAUM: 889.00M
BSVOEA Bridgeway Omni Small-Cap Value ETFAUM: 2.44B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B

News

latest 14 of 206
  • Nutex Health Named a 2026 Houston Top Workplace by Houston Chronicle (PR Newswire) +7.53%
  • Nutex Health Edges Past Estimates As Visit Growth Surges, But Falling Revenue Per Visit, Margin Compression And IDR Legislative Risk Cloud The Quarter (Earnings Whispers) -6.75%
  • NUTEX HEALTH REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS (PR Newswire) -5.64%
  • Nutex Health Must Prove Its Leaner Arbitration Cost Base Survives Without The One-Time Boost (Earnings Whispers)
  • Nutex Health Schedules 2026 Third Quarter Financial Results Release and Conference Call (PR Newswire)
  • Loading…
  • Nutex Health Approved for Dual Listing on Nasdaq Texas (PR Newswire)
  • NUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENT (PR Newswire)
  • Nutex Health Hospitals Earn Multiple Community Honors in Second Quarter 2026 (PR Newswire)
  • Fifth Circuit Rejects "Ghost Rates" in Federal QPA Calculations Under the No Surprises Act (PR Newswire)
  • NUTEX HEALTH OPENS WEST LITTLE ROCK EMERGENCY HOSPITAL IN ARKANSAS (PR Newswire)
  • Nutex Health Inc (NUTX) (Q2 2026) Earnings Call Highlights: Net Income Soars 3,100% as Revenue ... (GuruFocus.com)
  • NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS (PR Newswire) +6.67%
  • Nutex Health Schedules 2026 Second Quarter Financial Results Release and Conference Call (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-055.7105.5425.710217.6214.826
2026Q22026-08-069.3804.9549.378210.75215.035
2026Q12026-04-306.5203.9936.520216.49227.83
2025Q42026-03-051.6935.5571.620151.7258.823
2025Q32025-11-197.7601.8107.761267.8213.813
2025Q22025-11-18---2.952243.99--
2025Q12025-05-132.5603.0433.289211.79134.243
2024Q42025-03-3111.120-0.12311.179257.6281.113
2024Q32024-11-07-1.720-0.240-1.72378.7973.222
2024Q22024-08-08-0.070-0.290-0.04976.0868.201
2024Q12024-05-08-0.1000.000-0.07567.4564.801
2023Q42024-03-28-7.5000.000-7.01069.6769.701
2023Q32023-11-09-1.500-0.750-1.25062.7063.002
2023Q22023-08-09-1.500-0.750-0.79558.9062.052
2023Q12023-05-15-1.500-2.250-1.18756.3056.052
2022Q42023-03-02-3.000-2.250-3.40453.7249.952

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2022FY-100.5-100.5-100.36219.29215.5
2023FY-10.500-3.000-10.386247.65247.6
2024FY9.710-2.0239.692479.95303.48
2025FY10.48014.07010.480875.26982.4
2026FY-27.820--870.32
2027FY-27.635--960.29
2028FY-27.619--1,020
2029FY-32.740--1,115

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-09622226.94223.81231.8
2026Q4S2026-11-06621227.34223.81231.8
2026Q4S2026-11-05610228.4221.54239.4
2026Q4S2026-10-28610228.4221.54239.4
2026Q4S2026-10-23611228.4221.54239.4
2026Q4S2026-09-02511229.78223.81239.4
2026Q4S2026-08-14502228.3221.5239.4
2026Q4S2026-08-10501229.23221.5239.4
2026Q4S2026-08-07501229.25221.5239.4
2026Q4S2026-07-15500229.91224.8239.4
2026Q4S2026-06-24511229.91224.8239.4
2026Q4S2026-06-01411231.19227.08239.4
2026Q4S2026-05-04311231.65227.08239.4
2026Q4S2026-05-01311231.65227.08239.4

Estimate history

EPS, annual-5446.5-41856-294.065-175.79633.552-100.361-10.3869.69210.47823.2301
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.72311.1793.289-2.9527.7611.626.529.3785.713
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual0.0231.3671.3661.586331.531219.294247.646479.949875.257796.53
Period201720182019202020212022202320242025TTM
Sales, quarterly78.795257.618211.789243.985267.804151.679216.485210.752217.613
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual0.00200.0310.0353.9524.3354.5115.5117.0876.858
Period201720182019202020212022202320242025MRQ
Shares, quarterly5.2165.5115.9516.5956.9057.0876.9526.8446.858
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue796.53875.26479.95247.65219.29331.531.591.371.37
Cost of Goods Sold Incl. D&A415.86430.98283.69212.87205.84152.251.131.010.51
Gross Profit380.67444.28196.2634.7713.45179.280.450.360.86
Selling, General and Administrative Excl. Other69.67168.6658.4836.0718.035.463.985.001.70
Research and Development-----0.290.560.770.55
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income311.00275.62137.78-1.29-4.58173.82-3.52-4.64-0.84
Interest Expense19.1922.2319.9316.3212.496.200.340.090.11
Unusual Expense0.000.008.6930.48402.023.553.612.390.00
Net Income Before Taxes292.08244.78109.83-48.49-419.65169.49-5.69-7.12-0.95
Income Taxes59.0564.4215.02-5.0713.090.970.000.000.00
Consolidated Net Income233.03180.3694.81-43.42-432.74168.53-5.69-7.12-0.95
Net Income From Continuing Operations164.7170.7952.10-45.79-424.78132.59-5.69-7.12-0.95
Net Income164.7170.7952.10-45.79-424.78132.59-5.79-7.12-0.95
EPS (Recurring)23.3910.4810.80-5.55-33.8734.18-99.01-225.02-41,856.15
EPS (Basic, Before Extraordinaries)23.8311.1310.23-10.39-100.3633.55-175.80-294.06-41,856.00
EPS (Diluted)23.2310.489.69-10.39-100.3633.55-175.80-294.06-41,856.00
EBITDA332.62296.15156.7516.308.62181.58-3.28-4.46-0.84
Non-Operating Income (Expense)0.27-8.620.67-0.40-0.565.421.780.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-92.4313.082.240.154.032.570.450.51
Price To Earnings Ratio8.028.02-------
Price To Sales Ratio1.871.270.360.485.507.374.215.310.01
Gross Margin47.7950.7640.8914.046.1354.0828.6426.0962.83
Operating Margin39.0431.4928.71-0.52-2.0952.43-222.03-339.63-61.48
Net Margin20.688.0910.85-18.49-193.7039.99-365.22-520.82-69.50
Shares Outstanding6.867.095.514.514.333.950.040.030.00
Market Capitalization1,277.821,277.82172.30120.731,234.56198.727.139.301.02

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue217.61210.75216.49151.68267.80243.99211.79257.62
Cost of Goods Sold Incl. D&A116.0969.47124.75105.54112.92119.0693.45115.99
Gross Profit101.53141.2891.7346.14154.88124.92118.34141.63
Selling, General and Administrative Excl. Other24.4319.5610.4615.2224.5191.2537.6827.35
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income77.10121.7281.2730.92130.3733.6880.66114.27
Interest Expense4.864.674.684.985.455.686.125.05
Unusual Expense0.000.000.000.000.000.000.000.52
Net Income Before Taxes72.54117.0876.5625.89123.9423.7371.22108.65
Income Taxes15.2020.7713.809.2927.147.5920.419.15
Consolidated Net Income57.3496.3262.7616.6196.8016.1450.8199.50
Net Income From Continuing Operations40.2365.8446.8111.8355.44-17.7021.2261.61
Net Income40.2365.8446.8111.8355.44-17.7021.2261.61
EPS (Recurring)5.719.386.521.627.76-2.953.2911.25
EPS (Basic, Before Extraordinaries)5.879.586.701.688.27-2.953.7411.18
EPS (Diluted)5.719.386.521.627.76-2.953.2911.18
EBITDA82.72127.0386.7636.10135.3738.9385.75119.56
Non-Operating Income (Expense)0.300.04-0.02-0.05-0.98-4.27-3.33-0.04
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.842.28-3.09-10.4462.2121.8411.54
Price To Earnings Ratio8.0213.209.788.548.6810.465.07-
Price To Sales Ratio1.871.420.781.370.760.940.490.36
Gross Margin46.6567.0442.3730.4257.8351.2055.8854.98
Operating Margin35.4357.7537.5420.3848.6813.8038.0944.36
Net Margin18.4931.2421.627.8020.70-7.2510.0223.92
Shares Outstanding6.866.846.957.096.916.605.955.51
Market Capitalization1,277.821,175.95662.271,164.18573.96691.56255.70172.30

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments185.8743.5822.0034.2636.120.031.070.120.01
Short Term Receivables325.42236.0562.7858.32114.760.020.100.190.01
Inventories2.872.853.393.532.810.000.030.000.00
Other Current Assets24.6610.002.681.870.320.110.050.000.04
Total Current Assets538.81292.4890.8597.97154.020.161.240.310.06
Net Property, Plant & Equipment343.90324.69269.39295.15238.360.010.330.010.00
Total Investments and Advances0.000.000.000.000.000.000.100.000.00
Long-Term Note Receivable------0.000.12-
Intangible Assets35.1529.4537.5838.201.820.005.010.003.27
Deferred Tax Assets75.7274.54-------
Other Assets0.660.710.430.420.460.000.010.020.00
Total Assets994.24721.87398.25431.75394.650.176.690.453.33
Short Term Debt Incl. Current Port. of LT Debt23.3027.7320.0821.0913.170.342.530.480.39
Accounts Payable48.9710.4225.2827.5317.650.701.750.570.35
Income Tax Payable0.8726.53-1.030.00----
Other Current Liabilities84.7789.5412.965.216.860.120.33-0.000.23
Total Current Liabilities157.91154.2358.3154.8637.691.154.611.040.96
Long Term Debt328.09312.56255.68246.11165.380.150.220.900.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities84.8166.555.1510.451.75----
Other Liabilities0.000.000.000.000.000.000.000.000.00
Total Liabilities570.81533.34319.14311.42203.071.304.831.950.96
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity329.45132.4461.4595.86114.65-1.131.86-1.502.37
Total Shareholders Equity329.45132.4461.4595.86114.65-1.131.86-1.502.37
Accumulated Minority Interest93.9956.0917.6524.4676.930.000.000.000.00
Total Equity423.44188.5379.11120.33191.58-1.131.86-1.502.37
Total Liabilities & Stockholders Equity994.24721.87398.25431.75394.650.176.690.453.33
Book Value Per Share46.4924.0313.6222.1129.01-32.1959.96-144,512.061,529.07
Tangible Book Value Per Share41.5318.695.2913.3028.55-32.19-101.60-144,512.06-580.21
Full-Time Employees9448008001,15024141266
Price to Book Ratio2.932.731.3411.172.64-6.295.000.830.97
Return on Assets8.259.30-11.03-164.1767.17-165.83-152.86-50.30-312.92
Return on Equity30.6553.74-58.21-496.82233.61-1,570.42-460.40-218.01-
Return on Invested Capital10.7711.71-14.44-124.2147.35--341.80--256.47
Quick Ratio3.391.881.501.724.010.140.260.290.06
Current Ratio3.411.901.561.794.090.140.270.290.06

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income233.03180.3694.81-43.42-432.74168.53-5.53-7.12-0.95
Depreciation21.6220.5318.9717.5913.207.760.110.170.00
Other Funds (Non Cash)-48.36117.9126.3634.46400.84-5.614.692.980.16
Funds from Operations202.13335.87127.012.92-13.71170.68-0.73-3.97-0.79
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital56.32-87.74-103.85-1.6664.322.75-0.74-0.070.31
Income Taxes Payable3.96-25.6726.53------
Cash from Operating Activities258.45248.1223.151.2650.61173.43-1.48-4.04-0.48
Capital Expenditures-10.35-2.53-2.30-9.50-14.63-36.930.00-0.080.00
Net Assets From Acquisitions1.990.00-0.36-1.74-2.42-0.050.00-0.58-0.12
Sale of Fixed Assets and Businesses0.000.000.000.0012.720.000.000.000.00
Purchase or Sale of Investments-1.341.60-2.940.000.000.000.10-0.100.00
Purchase of Investments0.000.00-2.940.000.000.000.00-0.100.00
Sale Or Maturity of Investments-1.341.600.000.000.000.000.100.000.00
Other Uses-4.31-4.310.000.000.000.00-0.160.000.00
Other Sources0.000.000.000.000.000.000.000.010.00
Cash from Investing Activities-14.02-5.24-5.61-11.24-4.34-36.98-0.06-0.75-0.12
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-55.44-5.0011.580.004.760.000.124.110.00
Repurchase of Common Pref Stock-55.69-5.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.250.0011.580.004.760.000.124.110.00
Proceedsfrom Stock Options0.000.009.200.000.000.000.124.110.00
Issuance or Reduction of Debt, Net-18.15-19.44-7.402.65-5.59-3.220.381.620.34
Change in Long Term Debt-12.91-16.63-7.581.90-8.14-2.360.350.000.00
Issuance of Long Term Debt0.660.007.0121.860.8219.610.460.000.00
Reduction of Long Term Debt-13.57-16.63-14.60-19.96-8.96-21.97-0.110.000.00
Net Financing Active Other Cash Flow-83.63-73.51-3.08-4.92-47.31-122.630.000.000.37
Other Financing Activities Uses-85.81-74.28-6.44-5.21-51.82-144.390.000.000.00
Cash from Financing Activities-157.22-97.951.09-2.27-48.13-125.850.505.730.70
Net Change in Cash87.22144.9318.64-12.25-1.8610.60-1.040.950.11
Free Cash Flow248.10245.6020.85-8.2435.97136.51-1.48-4.12-0.48
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow6.014.538.35-33.5317.89---
Deferred Taxes & Investment Tax Credit-17.08-13.13-5.715.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments253.56207.11210.64185.87166.0596.73
Short Term Receivables360.84356.70345.90325.42406.86354.96
Inventories5.144.214.682.873.162.27
Other Current Assets13.7017.6418.4324.6616.5919.06
Total Current Assets633.24585.65579.65538.81592.65473.02
Net Property, Plant & Equipment361.21340.92342.18343.90335.89326.06
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets34.1734.5034.8235.1535.4728.80
Deferred Tax Assets---75.720.0012.85
Other Assets3.753.560.670.660.500.29
Total Assets1,032.38964.63957.32994.24964.52841.03
Short Term Debt Incl. Current Port. of LT Debt17.2618.1026.4123.3032.5335.97
Accounts Payable15.409.9650.3748.9749.5630.05
Income Tax Payable3.964.0115.590.870.008.36
Other Current Liabilities96.3285.1592.0684.77103.37120.49
Total Current Liabilities132.94117.22184.44157.91185.46194.87
Long Term Debt347.72329.23322.67328.09326.07309.28
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities10.8010.868.1684.8114.96-
Other Liabilities0.000.000.000.000.000.00
Total Liabilities491.47457.32515.26570.81526.49504.15
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity435.57394.32346.29329.45317.17235.25
Total Shareholders Equity435.57394.32346.29329.45317.17235.25
Accumulated Minority Interest105.34113.0095.7693.99120.87101.63
Total Equity540.91507.31442.05423.44438.03336.88
Total Liabilities & Stockholders Equity1,032.38964.63957.32994.24964.52841.03
Book Value Per Share63.5257.6249.8146.4945.9335.67
Tangible Book Value Per Share58.5352.5844.8141.5340.7931.30
Full-Time Employees1,3731,3171,005944--
Price to Book Ratio2.933.432.043.582.903.49
Return on Assets16.5019.9311.218.2517.198.92
Return on Equity43.7657.1636.8430.6563.8637.82
Return on Invested Capital5.149.107.001.808.62-3.25
Quick Ratio4.724.963.123.393.182.42
Current Ratio4.765.003.143.413.202.43

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income57.3496.3262.7616.6196.8016.14
Depreciation5.625.325.495.195.005.25
Other Funds (Non Cash)7.41-49.42-3.88-2.4613.4779.00
Funds from Operations70.3154.9263.4413.47143.0898.03
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital8.04-20.7212.0856.92-43.56-70.77
Income Taxes Payable-0.04-11.5914.730.87-8.36-37.77
Cash from Operating Activities78.3534.2075.5270.3999.5127.26
Capital Expenditures-5.20-2.54-1.20-1.41-0.30-0.75
Net Assets From Acquisitions0.000.000.001.990.00-1.99
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.00-1.340.002.94
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.00-1.340.002.94
Other Uses0.000.000.00-4.310.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-5.20-2.54-1.20-5.07-0.300.20
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.17-18.88-31.73-5.000.000.00
Repurchase of Common Pref Stock-0.00-18.96-31.73-5.000.000.00
Sale of Common Pref Stock0.170.070.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-2.10-3.21-3.70-9.14-6.57-4.28
Change in Long Term Debt-2.07-3.16-3.11-4.58-4.02-5.01
Issuance of Long Term Debt0.930.000.00-0.270.010.10
Reduction of Long Term Debt-3.00-3.16-3.11-4.30-4.03-5.11
Net Financing Active Other Cash Flow-24.77-13.10-14.12-31.65-23.32-11.17
Other Financing Activities Uses-25.09-13.26-15.36-32.10-23.40-11.41
Cash from Financing Activities-26.69-35.19-49.55-45.79-29.90-15.45
Net Change in Cash46.45-3.5324.7719.5369.3112.00
Free Cash Flow73.1431.6674.3268.9899.2126.51
Price to Free Cash Flow6.014.382.544.904.218.97

Revenue breakdown

United States2024: 479.95M 2025: 875.26M
Hospital Division2024: 449.06M 2025: 844.16M
Population Health Management Division2024: 30.89M 2025: 31.10M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3025.26%1.2M4.6M154.63K
2026-10-1526.89%1.2M4.6M155.22K
2026-09-3027.18%1.3M4.6M150.97K
2026-09-1526.83%1.2M4.6M146.16K
2026-08-3125.22%1.2M4.6M141.23K
2026-08-1424.51%1.1M4.6M139.25K
2026-07-3123.96%1.1M4.6M138.78K
2026-07-1522.68%1.0M4.6M150.82K
2026-06-3023.91%1.1M4.6M157.14K
2026-06-1524.09%1.1M4.6M167.98K
2026-05-2922.86%1.1M4.7M190.12K
2026-05-1519.33%0.9M4.7M193.25K
2026-04-3021.03%1.0M4.7M209.48K
2026-04-1519.93%1.0M4.8M205.83K
2026-03-3119.85%1.0M5.0M201.58K
2026-03-1319.25%1.0M5.0M196.35K
2026-02-2718.52%0.9M5.0M184.99K
2026-02-1317.30%0.9M5.1M200.72K
2026-01-3016.69%0.8M5.1M169.88K
2026-01-1516.20%0.8M5.1M160.71K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-058-KCurrent report2026-11-05SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-09-228-A12BSEC
2026-09-22CERTSEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-18SEC
2026-09-118-KCurrent report2026-09-10SEC
2026-08-318-KCurrent report2026-08-31SEC
2026-08-248-KCurrent report2026-08-24SEC
2026-08-138-KCurrent report2026-08-11SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-07-218-KCurrent report2026-07-15SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-28SEC
2026-05-07SCHEDULE 13G/ASEC
2026-04-308-KCurrent report2026-04-30SEC
2026-04-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-27SCHEDULE 13GSEC
2026-04-244Statement of changes in beneficial ownership of securities2026-04-23SEC
2026-04-244Statement of changes in beneficial ownership of securities2026-04-23SEC
2026-04-244Statement of changes in beneficial ownership of securities2026-04-23SEC
2026-04-244Statement of changes in beneficial ownership of securities2026-04-23SEC
2026-04-238-KCurrent report2026-04-23SEC
2026-04-104Statement of changes in beneficial ownership of securities2026-04-09SEC
2026-03-244Statement of changes in beneficial ownership of securities2026-03-11SEC
2026-03-234Statement of changes in beneficial ownership of securities2026-03-19SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090043.49K1
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-0345.70K400
2026-020000
2026-010000
2025-120000
2025-11102.53K100

Institutional holders

Manager% owned
Pertento Partners LLP6.56%
BlackRock, Inc.5.92%
AMERICAN CENTURY COMPANIES INC3.45%
VANGUARD CAPITAL MANAGEMENT LLC3.14%
STATE STREET CORP1.90%
GEODE CAPITAL MANAGEMENT, LLC1.86%
D. E. Shaw & Co., Inc.1.42%
UBS Group AG1.19%
WINMILL & CO. INC0.95%
Focus Partners Wealth0.88%

Funds

Fund% owned
Avantis U.S. Small Cap Value ETF3.58%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.23%
iShares Russell 2000 ETF1.91%
BEXIL INVESTMENT TRUST0.90%
VANGUARD EXTENDED MARKET INDEX FUND0.84%
Fidelity Small Cap Index Fund0.80%
iShares Russell 2000 Growth ETF0.68%
Pacer US Small Cap Cash Cows 100 ETF0.64%
EA Bridgeway Omni Small-Cap Value ETF0.46%
VANGUARD RUSSELL 2000 INDEX FUND0.42%

OakChart. NUTX. Cached 15 minutes.